Cargando…

Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study

OBJECTIVES: We aimed to investigate prognostic effects of plasma levels of ghrelin before and after gastrectomy in gastric cancer (GC). METHODS: We followed 81 GC patients up to 3 years in this study. They were candidates for curative gastrectomy with or without neoadjuvant chemotherapy. Plasma leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Soleyman-Jahi, Saeed, Abdirad, Afshin, Fallah, Amir Afraz, Ghasemi, Sevil, Sadeghi, Fatemeh, Heidari, Reza, Mahmoodzadeh, Habibollah, Zendehdel, Kazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288598/
https://www.ncbi.nlm.nih.gov/pubmed/28055030
http://dx.doi.org/10.1038/ctg.2016.64
_version_ 1782504356318281728
author Soleyman-Jahi, Saeed
Abdirad, Afshin
Fallah, Amir Afraz
Ghasemi, Sevil
Sadeghi, Fatemeh
Heidari, Reza
Mahmoodzadeh, Habibollah
Zendehdel, Kazem
author_facet Soleyman-Jahi, Saeed
Abdirad, Afshin
Fallah, Amir Afraz
Ghasemi, Sevil
Sadeghi, Fatemeh
Heidari, Reza
Mahmoodzadeh, Habibollah
Zendehdel, Kazem
author_sort Soleyman-Jahi, Saeed
collection PubMed
description OBJECTIVES: We aimed to investigate prognostic effects of plasma levels of ghrelin before and after gastrectomy in gastric cancer (GC). METHODS: We followed 81 GC patients up to 3 years in this study. They were candidates for curative gastrectomy with or without neoadjuvant chemotherapy. Plasma levels of total and active ghrelins before and after the operation were assessed. Association of plasma levels of ghrelin with survival were assessed and adjusted for other potential prognostic factors using Cox regression analyses. RESULTS: Both total and active ghrelins dropped after gastrectomy (P<0.001 for both). Multiple Cox models revealed worse survival for patients with postoperative total ghrelins below median (hazards ratio (HR)=2.33, 95% confidence interval (CI): 1.01–5.41) or 25th percentile (HR=4.29, 95% CI: 1.48–12.44) compared with patients with higher ghrelin levels. In case of preoperative total ghrelin, patients with either second or third quartiles of plasma ghrelin showed worse survival compared with patients with the lowest quartile (HR=2.67, 95% CI: 1.11–6.38 for second quartile, and HR=2.32, 95% CI: 1.01–5.35 for third quartile vs. the lowest quartile). However, there was no difference between patients with the highest and lowest quartiles (HR=0.78, 95% CI: 0.22–2.73). Similar pattern was observed for preoperative active ghrelin (HR=4.92, 95% CI: 1.80–13.54 for second quartile, and HR=2.87, 95% CI: 1.11–7.38 for third quartile vs. the lowest quartile). Advanced TNM stage (HR=4.88, 95% CI: 1.10–21.77), cachexia (HR=2.99, 95% CI: 1.35–6.63), and receiving no neoadjuvant chemotherapy (HR=2.02, 95% CI: 1.04–3.92) were other poor prognostic factors. CONCLUSIONS: Preoperative and postoperative plasma levels of ghrelin could predict survival of GC patients with different patterns. This prognostic effect was independent of stage and cachexia. Measurement of plasma ghrelin in GC patients could complement conventional staging for more precise risk-stratification of the patients. Extrinsic admirations of ghrelin after total gastrectomy has potentials to improve survival of GC patients.
format Online
Article
Text
id pubmed-5288598
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52885982017-02-07 Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study Soleyman-Jahi, Saeed Abdirad, Afshin Fallah, Amir Afraz Ghasemi, Sevil Sadeghi, Fatemeh Heidari, Reza Mahmoodzadeh, Habibollah Zendehdel, Kazem Clin Transl Gastroenterol Original Contributions OBJECTIVES: We aimed to investigate prognostic effects of plasma levels of ghrelin before and after gastrectomy in gastric cancer (GC). METHODS: We followed 81 GC patients up to 3 years in this study. They were candidates for curative gastrectomy with or without neoadjuvant chemotherapy. Plasma levels of total and active ghrelins before and after the operation were assessed. Association of plasma levels of ghrelin with survival were assessed and adjusted for other potential prognostic factors using Cox regression analyses. RESULTS: Both total and active ghrelins dropped after gastrectomy (P<0.001 for both). Multiple Cox models revealed worse survival for patients with postoperative total ghrelins below median (hazards ratio (HR)=2.33, 95% confidence interval (CI): 1.01–5.41) or 25th percentile (HR=4.29, 95% CI: 1.48–12.44) compared with patients with higher ghrelin levels. In case of preoperative total ghrelin, patients with either second or third quartiles of plasma ghrelin showed worse survival compared with patients with the lowest quartile (HR=2.67, 95% CI: 1.11–6.38 for second quartile, and HR=2.32, 95% CI: 1.01–5.35 for third quartile vs. the lowest quartile). However, there was no difference between patients with the highest and lowest quartiles (HR=0.78, 95% CI: 0.22–2.73). Similar pattern was observed for preoperative active ghrelin (HR=4.92, 95% CI: 1.80–13.54 for second quartile, and HR=2.87, 95% CI: 1.11–7.38 for third quartile vs. the lowest quartile). Advanced TNM stage (HR=4.88, 95% CI: 1.10–21.77), cachexia (HR=2.99, 95% CI: 1.35–6.63), and receiving no neoadjuvant chemotherapy (HR=2.02, 95% CI: 1.04–3.92) were other poor prognostic factors. CONCLUSIONS: Preoperative and postoperative plasma levels of ghrelin could predict survival of GC patients with different patterns. This prognostic effect was independent of stage and cachexia. Measurement of plasma ghrelin in GC patients could complement conventional staging for more precise risk-stratification of the patients. Extrinsic admirations of ghrelin after total gastrectomy has potentials to improve survival of GC patients. Nature Publishing Group 2017-01 2017-01-05 /pmc/articles/PMC5288598/ /pubmed/28055030 http://dx.doi.org/10.1038/ctg.2016.64 Text en Copyright © 2017 The Author(s) the American College of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/4.0/ Clinical and Translational Gastroenterology is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Original Contributions
Soleyman-Jahi, Saeed
Abdirad, Afshin
Fallah, Amir Afraz
Ghasemi, Sevil
Sadeghi, Fatemeh
Heidari, Reza
Mahmoodzadeh, Habibollah
Zendehdel, Kazem
Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study
title Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study
title_full Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study
title_fullStr Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study
title_full_unstemmed Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study
title_short Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study
title_sort prognostic significance of preoperative and postoperative plasma levels of ghrelin in gastric cancer: 3-year survival study
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288598/
https://www.ncbi.nlm.nih.gov/pubmed/28055030
http://dx.doi.org/10.1038/ctg.2016.64
work_keys_str_mv AT soleymanjahisaeed prognosticsignificanceofpreoperativeandpostoperativeplasmalevelsofghreliningastriccancer3yearsurvivalstudy
AT abdiradafshin prognosticsignificanceofpreoperativeandpostoperativeplasmalevelsofghreliningastriccancer3yearsurvivalstudy
AT fallahamirafraz prognosticsignificanceofpreoperativeandpostoperativeplasmalevelsofghreliningastriccancer3yearsurvivalstudy
AT ghasemisevil prognosticsignificanceofpreoperativeandpostoperativeplasmalevelsofghreliningastriccancer3yearsurvivalstudy
AT sadeghifatemeh prognosticsignificanceofpreoperativeandpostoperativeplasmalevelsofghreliningastriccancer3yearsurvivalstudy
AT heidarireza prognosticsignificanceofpreoperativeandpostoperativeplasmalevelsofghreliningastriccancer3yearsurvivalstudy
AT mahmoodzadehhabibollah prognosticsignificanceofpreoperativeandpostoperativeplasmalevelsofghreliningastriccancer3yearsurvivalstudy
AT zendehdelkazem prognosticsignificanceofpreoperativeandpostoperativeplasmalevelsofghreliningastriccancer3yearsurvivalstudy